KATHY COOLEY: Open Payments
NPI 1710176946 · EASTPOINTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 58 payments from 13 companies in 2025. Trend: 2023 $1,434 · 2024 $956 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $295 |
| ABBVIE INC. | 15 | $242 |
| AstraZeneca Pharmaceuticals LP | 5 | $235 |
| Indivior Inc. | 5 | $161 |
| Otsuka America Pharmaceutical, Inc. | 4 | $106 |
| Exact Sciences Corporation | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Novo Nordisk Inc | 1 | $26 |
| Orexo US, Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $18 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, SUBLOCADE, REXULTI, Cologuard Collection Kit, TRELEGY ELLIPTA, MAVYRET.
Industry payments across MI — which companies pay providers there.
